Chemoresistance in gliomas, Molecular and Cellular Biochemistry, vol.71, issue.6, pp.71-80, 2008. ,
DOI : 10.1007/s11010-008-9722-8
The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007. ,
DOI : 10.1007/s00401-007-0243-4
Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002. ,
DOI : 10.3322/canjclin.49.1.33
Low-grade hemispheric gliomas in adults: a critical review of extent of resection as a factor influencing outcome, Journal of Neurosurgery, vol.95, issue.5, pp.735-745, 2001. ,
DOI : 10.3171/jns.2001.95.5.0735
Advances in the Treatment of Malignant Gliomas, Current Oncology Reports, vol.27, issue.1, pp.26-33, 2010. ,
DOI : 10.1007/s11912-009-0077-4
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial, The Lancet Oncology, vol.10, issue.5, pp.459-466, 2009. ,
DOI : 10.1016/S1470-2045(09)70025-7
Strat??gies th??rapeutiques pour le traitement des gliomes, Revue Neurologique, vol.164, issue.6-7, pp.523-530, 2008. ,
DOI : 10.1016/j.neurol.2008.03.012
Combined Radio- and Chemotherapy of Brain Tumours in Adult Patients, Clinical Oncology, vol.21, issue.7, pp.515-524, 2009. ,
DOI : 10.1016/j.clon.2009.05.003
New ferrocene containing peptide conjugates: Synthesis and effect on human leukemia (HL-60) cells, Biopolymers, vol.77, issue.2, pp.108-114, 2007. ,
DOI : 10.1002/bip.20696
New metal complexes as potential therapeutics, Current Opinion in Chemical Biology, vol.7, issue.4, pp.481-489, 2003. ,
DOI : 10.1016/S1367-5931(03)00081-4
A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents, ChemMedChem, vol.11, issue.5, pp.551-559, 2006. ,
DOI : 10.1002/cmdc.200500035
New trends for metal complexes with anticancer activity, Current Opinion in Chemical Biology, vol.12, issue.2 ,
DOI : 10.1016/j.cbpa.2007.11.013
Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro, Journal of Medicinal Chemistry, vol.48, issue.12, pp.3937-3940, 2005. ,
DOI : 10.1021/jm050251o
URL : https://hal.archives-ouvertes.fr/hal-01230403
Ferrocene-mediated protoncoupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates ,
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008. ,
DOI : 10.1016/j.jconrel.2008.05.027
URL : https://hal.archives-ouvertes.fr/inserm-00343557
Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment, International Journal of Pharmaceutics, vol.347, issue.1-2, pp.128-135, 2008. ,
DOI : 10.1016/j.ijpharm.2007.06.033
URL : https://hal.archives-ouvertes.fr/hal-00180710
Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2010. ,
DOI : 10.1007/s11095-009-0006-0
Convection-Enhanced Drug Delivery: Increased Efficacy and Magnetic Resonance Image Monitoring, Cancer Research, vol.65, issue.15, pp.6858-6863, 2005. ,
DOI : 10.1158/0008-5472.CAN-05-0161
Strategy for effective brain drug delivery, European Journal of Pharmaceutical Sciences, vol.40, issue.5, pp.385-403, 2010. ,
DOI : 10.1016/j.ejps.2010.05.003
188Re-loaded lipid nanocapsules as a promising radiopharmaceutical carrier for internal radiotherapy of malignant gliomas, Eur J Nucl Med Mol Imaging, vol.35, pp.1838-1846, 2008. ,
URL : https://hal.archives-ouvertes.fr/inserm-00343438
Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2010. ,
DOI : 10.1007/s11095-009-0006-0
Convection-enhanced delivery of nanocarriers for the treatment of brain tumors, Biomaterials, vol.30, issue.12, pp.2302-2318, 2009. ,
DOI : 10.1016/j.biomaterials.2009.01.003
Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009. ,
DOI : 10.1016/j.ijpharm.2009.04.026
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010. ,
DOI : 10.2217/nnm.10.113
New paradigms for synthetic pathways inspired by bioorganometallic chemistry, Journal of Organometallic Chemistry, vol.600, issue.1-2, pp.23-36, 2000. ,
DOI : 10.1016/S0022-328X(00)00036-X
The first organometallic antioestrogens and their antiproliferative effects, Comptes Rendus de l'Academie des Sciences -Series IIc: Chemistry, pp.89-93, 2000. ,
DOI : 10.1016/S1387-1609(00)00118-3
Intracarotid Delivery of Drugs, Anesthesiology, vol.109, issue.3, pp.543-564, 2008. ,
DOI : 10.1097/ALN.0b013e318182c81b
Improving the detection of low concentration metabolites in magnetic resonance spectroscopy by digital filtering, Medical & Biological Engineering & Computing, vol.39, issue.1, pp.244-246, 1999. ,
DOI : 10.1007/BF02513293
The 2007 WHO Classification of Tumours of the Central Nervous System, Acta Neuropathologica, vol.64, issue.2, pp.97-109, 2007. ,
DOI : 10.1007/s00401-007-0243-4
The Effects of Hyperosmolarity on the Viability and Function of Endothelial Cells, Journal of Surgical Research, vol.60, issue.1, pp.122-128, 1996. ,
DOI : 10.1006/jsre.1996.0020
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010. ,
DOI : 10.1016/j.biomaterials.2009.09.044
URL : https://hal.archives-ouvertes.fr/inserm-00491402
Intra-Arterial Chemotherapy, Handbook of Brain Tumor Chemotherapy, pp.247-261, 2006. ,
DOI : 10.1016/B978-012088410-0/50055-X
Intra-arterial carboplatin and intravenous etoposide for the treatment of metastatic brain tumors, J Neurooncol, vol.61, pp.35-44, 2003. ,
The blood-brain barrier: Bottleneck in brain drug development, NeuroRX, vol.550, issue.1, 2005. ,
DOI : 10.1602/neurorx.2.1.3
Global cancer statistics, CA: A Cancer Journal for Clinicians, vol.49, issue.1, pp.74-108, 2002. ,
DOI : 10.3322/canjclin.49.1.33
Hypernatrémie contrôlée. Annales Françaises d'Anesthésie et de Réanimation, pp.828-837, 2006. ,
Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.217-230, 2000. ,
DOI : 10.1023/A:1007049806660
Enhancement of ACNU treatment of the BT4an rat glioma by local brain hyperthermia and intra-arterial drug administration, European Journal of Cancer, vol.31, issue.11, pp.1869-1874, 1995. ,
DOI : 10.1016/0959-8049(95)00381-R
New paradigms for synthetic pathways inspired by bioorganometallic chemistry, Journal of Organometallic Chemistry, vol.600, issue.1-2, pp.23-36, 2000. ,
DOI : 10.1016/S0022-328X(00)00036-X
Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro, Journal of Medicinal Chemistry, vol.48, issue.12, pp.3937-3940, 2005. ,
DOI : 10.1021/jm050251o
URL : https://hal.archives-ouvertes.fr/hal-01230403
Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone-Dependent and Hormone-Independent Breast Cancer Cell Lines, Chemistry - A European Journal, vol.9, issue.21, pp.5223-5236, 2003. ,
DOI : 10.1002/chem.200305024
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008. ,
DOI : 10.1016/j.jconrel.2008.05.027
URL : https://hal.archives-ouvertes.fr/inserm-00343557
Nanoparticles loaded with ferrocenyl tamoxifen derivatives for breast cancer treatment, International Journal of Pharmaceutics, vol.347, issue.1-2 ,
DOI : 10.1016/j.ijpharm.2007.06.033
URL : https://hal.archives-ouvertes.fr/hal-00180710
A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002. ,
DOI : 10.1023/A:1016121319668
Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009. ,
DOI : 10.1016/j.ijpharm.2009.04.026
Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, International Journal of Pharmaceutics, vol.379, issue.2, pp.317-323, 2009. ,
DOI : 10.1016/j.ijpharm.2009.05.031
URL : https://hal.archives-ouvertes.fr/hal-01230396
Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006. ,
DOI : 10.1016/j.biomaterials.2006.03.039
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010. ,
DOI : 10.2217/nnm.10.113
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution, European Journal of Nuclear Medicine and Molecular Imaging, vol.242, issue.5, pp.602-607, 2006. ,
DOI : 10.1007/s00259-005-0007-0
URL : http://doi.org/10.1007/s00259-005-0007-0
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review, Journal of Controlled Release, vol.65, issue.1-2, pp.271-284, 2000. ,
DOI : 10.1016/S0168-3659(99)00248-5
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010. ,
DOI : 10.1016/j.biomaterials.2009.09.044
URL : https://hal.archives-ouvertes.fr/inserm-00491402
Molecular mechanisms of brain tumor edema, Neuroscience, vol.129, issue.4, pp.1011-1020, 2004. ,
DOI : 10.1016/j.neuroscience.2004.05.044
The first organometallic antioestrogens and their antiproliferative effects. Comptes Rendus de l'Academie des Sciences -Series IIc, Chemistry, vol.3, issue.2, pp.89-93, 2000. ,
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Molecular Cancer Therapeutics, vol.5, issue.7, pp.1710-1722, 2006. ,
DOI : 10.1158/1535-7163.MCT-06-0289
URL : https://hal.archives-ouvertes.fr/hal-00358958
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006. ,
DOI : 10.1002/jbm.a.30711
Interactions of nanoparticles bearing heparin or dextran covalently bound to poly(methyl methacrylate) with the complement system, Life Sciences, vol.62, issue.8, pp.775-785, 1998. ,
DOI : 10.1016/S0024-3205(97)01175-2
Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester, Cancer Res, vol.42, issue.4, pp.1530-1536, 1982. ,
Electrokinetic properties of noncharged lipid nanocapsules: Influence of the dipolar distribution at the interface, ELECTROPHORESIS, vol.15, issue.11, pp.2066-2075, 2005. ,
DOI : 10.1002/elps.200410145
Pegylated Nanocapsules Produced by an Organic Solvent-Free Method: Evaluation of their Stealth Properties, Pharmaceutical Research, vol.134, issue.109, pp.2190-2199, 2006. ,
DOI : 10.1007/s11095-006-9061-y
PEGylated PLGA nanoparticles for the improved delivery of doxorubicin, Nanomedicine: Nanotechnology, Biology and Medicine, vol.5, issue.4, pp.410-418, 2009. ,
DOI : 10.1016/j.nano.2009.02.002
Enhanced solubility and stability of PEGylated liposomal paclitaxel: In vitro and in vivo evaluation, International Journal of Pharmaceutics, vol.338, issue.1-2, pp.317-326, 2007. ,
DOI : 10.1016/j.ijpharm.2007.02.011
In vivo investigation of tolerance and antitumor activity of cisplatin-loaded PLGA-mPEG nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.71, issue.2, pp.190-195, 2009. ,
DOI : 10.1016/j.ejpb.2008.09.011
Phase I and Pharmacokinetic Study of Pegylated Liposomal CKD-602 in Patients with Advanced Malignancies, Clinical Cancer Research, vol.15, issue.4, pp.1466-1472, 2009. ,
DOI : 10.1158/1078-0432.CCR-08-1405
Complement Activation by Injectable Colloidal Drug Carriers ,
DOI : 10.1201/9780203492321.ch6
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin???PEG-liposome, International Journal of Pharmaceutics, vol.346, issue.1-2, pp.143-150, 2008. ,
DOI : 10.1016/j.ijpharm.2007.06.010
Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model, Journal of Neuro-Oncology, vol.59, issue.2, pp.181-189, 2007. ,
DOI : 10.1007/s11060-007-9406-3
The blood-brain barrier: Bottleneck in brain drug development, NeuroRX, vol.550, issue.1 ,
DOI : 10.1602/neurorx.2.1.3
The choroid plexuses and the barriers between the blood and the cerebrospinal fluid, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.183-196, 2000. ,
DOI : 10.1023/A:1007045605751
Liposome-mediated therapy of intracranial brain tumors in a rat model, Pharmaceutical Research, vol.14, issue.8, pp.992-998, 1997. ,
DOI : 10.1023/A:1012136925030
Hypoxia and the regulation of gene expression, Molecular Medicine Today, vol.4, issue.3, pp.122-129, 1998. ,
DOI : 10.1016/S1357-4310(97)01198-2
The hypoxic response of tumors is dependent on their microenvironment, Cancer Cell, vol.4, issue.2, pp.133-146, 2003. ,
DOI : 10.1016/S1535-6108(03)00194-6
VEGF in brain tumors, Journal of Neuro-Oncology, vol.50, issue.1/2, pp.109-120, 2000. ,
DOI : 10.1023/A:1006416003964
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010. ,
DOI : 10.2217/nnm.10.113
A novel phase inversion-based process for the preparation of lipid nanocarriers, Pharmaceutical Research, vol.19, issue.6, pp.875-880, 2002. ,
DOI : 10.1023/A:1016121319668
Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009. ,
DOI : 10.1016/j.ijpharm.2009.04.026
Brain targeting using novel lipid nanovectors, Journal of Controlled Release, vol.126, issue.1, pp.44-49, 2008. ,
DOI : 10.1016/j.jconrel.2007.11.001
URL : https://hal.archives-ouvertes.fr/inserm-00258097
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010. ,
DOI : 10.1016/j.biomaterials.2009.09.044
URL : https://hal.archives-ouvertes.fr/inserm-00491402
A Series of Unconjugated Ferrocenyl Phenols: Prospects as Anticancer Agents, ChemMedChem, vol.11, issue.5, pp.551-559, 2006. ,
DOI : 10.1002/cmdc.200500035
Modification of the Estrogenic Properties of Diphenols by the Incorporation of Ferrocene. Generation of Antiproliferative Effects in Vitro, Journal of Medicinal Chemistry, vol.48, issue.12, pp.3937-3940, 2005. ,
DOI : 10.1021/jm050251o
URL : https://hal.archives-ouvertes.fr/hal-01230403
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008. ,
DOI : 10.1016/j.jconrel.2008.05.027
URL : https://hal.archives-ouvertes.fr/inserm-00343557
Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, International Journal of Pharmaceutics, vol.379, issue.2, pp.317-323, 2009. ,
DOI : 10.1016/j.ijpharm.2009.05.031
URL : https://hal.archives-ouvertes.fr/hal-01230396
Neurofilaments Bind Tubulin and Modulate Its Polymerization, Journal of Neuroscience, vol.29, issue.35, pp.11043-11054, 2009. ,
DOI : 10.1523/JNEUROSCI.1924-09.2009
Opinion: Inflammation and necrosis promote tumour growth, Nature Reviews Immunology, vol.94, issue.8, pp.641-648, 2004. ,
DOI : 10.1038/21460
Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002. ,
DOI : 10.1006/cyto.1996.0074
Immunity, inflammation, and cancer. Cell 1. Khasraw M, Lassman AB: Advances in the treatment of malignant gliomas, Curr Oncol Rep, vol.12, issue.1, pp.26-33, 2010. ,
In vivo evaluation of intracellular drug-nanocarriers infused into intracranial tumours by convection-enhanced delivery: distribution and radiosensitisation efficacy, Journal of Neuro-Oncology, vol.28, issue.2, pp.195-205, 2010. ,
DOI : 10.1007/s11060-009-0012-4
Design of targeted lipid nanocapsules by conjugation of whole antibodies and antibody Fab??? fragments, Biomaterials, vol.28, issue.33, pp.4978-4990, 2007. ,
DOI : 10.1016/j.biomaterials.2007.05.014
URL : https://hal.archives-ouvertes.fr/inserm-00198713
Local Delivery of Ferrociphenol Lipid Nanocapsules Followed by External Radiotherapy as a Synergistic Treatment Against Intracranial 9L Glioma Xenograft, Pharmaceutical Research, vol.10, issue.1, pp.56-64, 2010. ,
DOI : 10.1007/s11095-009-0006-0
Morphological studies of rat brain tumors induced by N-nitrosomethylurea, Journal of Neurosurgery, vol.34, issue.3, pp.335-340, 1971. ,
DOI : 10.3171/jns.1971.34.3.0335
Morphological and immunochemical studies of rat glial tumors and clonal strains propagated in culture, Journal of Neurosurgery, vol.34, issue.3, pp.310-323, 1971. ,
DOI : 10.3171/jns.1971.34.3.0310
Current and future strategies for the treatment of malignant brain tumors, Pharmacology & Therapeutics, vol.98, issue.1, pp.71-108, 2003. ,
DOI : 10.1016/S0163-7258(03)00014-7
Apports des nanocapsules lipidiques dans le traitement local des gliomes malins: apllication à l'encapsulation de complexes lipophiles métalliques, Thèse de doctorat, 2008. ,
Enhanced delivery of iodine for synchrotron stereotactic radiotherapy by means of intracarotid injection and blood???brain barrier disruption: Quantitative iodine biodistribution studies and associated dosimetry, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.4, pp.1173-1182, 2005. ,
DOI : 10.1016/j.ijrobp.2004.12.026
URL : https://hal.archives-ouvertes.fr/inserm-00388910
Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine, Journal of Neuro-Oncology, vol.33, issue.1/2, pp.59-70, 1997. ,
DOI : 10.1023/A:1005769214899
Altered blood-brain barrier permeability and its effect on the distribution of Evans blue and sodium fluorescein in the rat brain applied by intracarotid injection, Physiol Res, vol.52, issue.5, pp.607-614, 2003. ,
The blood-brain and blood-tumor barriers: A review of strategies for increasing drug delivery, Neuro-Oncology, vol.2, issue.1, pp.45-59, 2000. ,
DOI : 10.1215/15228517-2-1-45
Intracarotid Delivery of Drugs, Anesthesiology, vol.109, issue.3, pp.543-564, 2008. ,
DOI : 10.1097/ALN.0b013e318182c81b
Osmotic opening of the blood-brain barrier: principles, mechanism, and therapeutic applications, Cellular and Molecular Neurobiology, vol.20, issue.2, pp.217-230, 2000. ,
DOI : 10.1023/A:1007049806660
Fractionated internal radiation with stereotaxic injection of 188Re-loaded lipid nanocapsules in a rat glioblastoma model, J Nucl Med, vol.50, p.578, 2009. ,
Characterization and detection of experimental rat gliomas using magnetic resonance imaging, Magnetic Resonance Materials in Physics, Biology and Medicine, vol.4, issue.3-6, pp.3-6, 2004. ,
DOI : 10.1007/s10334-004-0049-5
A new generation of anticancer, drug-loaded, colloidal vectors reverses multidrug resistance in glioma and reduces tumor progression in rats, Molecular Cancer Therapeutics, vol.5, issue.7, pp.1710-1722, 2006. ,
DOI : 10.1158/1535-7163.MCT-06-0289
URL : https://hal.archives-ouvertes.fr/hal-00358958
Opinion: Inflammation and necrosis promote tumour growth, Nature Reviews Immunology, vol.94, issue.8, pp.641-648, 2004. ,
DOI : 10.1038/21460
Inflammation and cancer, Nature, vol.2, issue.6917, pp.860-867, 2002. ,
DOI : 10.1006/cyto.1996.0074
Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake, Journal of Biomedical Materials Research Part A, vol.21, issue.3, pp.620-628, 2006. ,
DOI : 10.1002/jbm.a.30711
99mTc/188Re-labelled lipid nanocapsules as promising radiotracers for imaging and therapy: formulation and biodistribution, European Journal of Nuclear Medicine and Molecular Imaging, vol.242, issue.5, pp.602-607, 2006. ,
DOI : 10.1007/s00259-005-0007-0
Long-circulating DNA lipid nanocapsules as new vector for passive tumor targeting, Biomaterials, vol.31, issue.2, pp.321-329, 2010. ,
DOI : 10.1016/j.biomaterials.2009.09.044
URL : https://hal.archives-ouvertes.fr/inserm-00491402
Parameters influencing the stealthiness of colloidal drug delivery systems, Biomaterials, vol.27, issue.24, pp.4356-4373, 2006. ,
DOI : 10.1016/j.biomaterials.2006.03.039
Lipid nanocapsules loaded with an organometallic tamoxifen derivative as a novel drug-carrier system for experimental malignant gliomas, Journal of Controlled Release, vol.130, issue.2, pp.146-153, 2008. ,
DOI : 10.1016/j.jconrel.2008.05.027
URL : https://hal.archives-ouvertes.fr/inserm-00343557
The taxanes: an update, The Lancet, vol.355, issue.9210, pp.1176-1178, 2000. ,
DOI : 10.1016/S0140-6736(00)02074-2
The gastrointestinal stability of lipid nanocapsules, International Journal of Pharmaceutics, vol.379, issue.2, pp.260-265, 2009. ,
DOI : 10.1016/j.ijpharm.2009.05.069
The adaptation of lipid nanocapsule formulations for blood administration in animals, International Journal of Pharmaceutics, vol.379, issue.2, pp.266-269, 2009. ,
DOI : 10.1016/j.ijpharm.2009.05.033
Antitumor efficacy, pharmacokinetics, and biodistribution of NX 211: a low-clearance liposomal formulation of lurtotecan, Clin Cancer Res, vol.6, issue.7, pp.2903-2912, 2000. ,
Effective anti-tumor activity of oxaliplatin encapsulated in transferrin???PEG-liposome, International Journal of Pharmaceutics, vol.346, issue.1-2, pp.143-150, 2008. ,
DOI : 10.1016/j.ijpharm.2007.06.010
Enhancement of cisplatin efficacy by thalidomide in a 9L rat gliosarcoma model, Journal of Neuro-Oncology, vol.59, issue.2, pp.181-189, 2007. ,
DOI : 10.1007/s11060-007-9406-3
Nanoparticulate systems for brain delivery of drugs, Advanced Drug Delivery Reviews, vol.47, issue.1, pp.65-81, 2001. ,
DOI : 10.1016/S0169-409X(00)00122-8
Application of nanoparticles for the delivery of drugs to the brain, International Congress Series, vol.1277, pp.85-94, 2005. ,
DOI : 10.1016/j.ics.2005.02.014
Toxicological studies of doxorubicin bound to polysorbate 80-coated poly(butyl cyanoacrylate) nanoparticles in healthy rats and rats with intracranial glioblastoma, Toxicology Letters, vol.126, issue.2, pp.131-141, 2002. ,
DOI : 10.1016/S0378-4274(01)00456-8
Chemotherapy of glioblastoma in rats using doxorubicin-loaded nanoparticles, International Journal of Cancer, vol.74, issue.5, pp.759-767, 2004. ,
DOI : 10.1002/ijc.20048
Longcirculating PEGylated polycyanoacrylate nanoparticles as new drug carrier for brain delivery, Pharmaceutical Research, vol.18, issue.8, pp.1157-1166, 2001. ,
DOI : 10.1023/A:1010931127745
Indirect evidence that drug brain targeting using polysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity, Pharmaceutical Research, vol.16, issue.12, pp.1836-1842, 1999. ,
DOI : 10.1023/A:1018947208597
URL : https://hal.archives-ouvertes.fr/hal-00534822
PEG-coated nanospheres from amphiphilic diblock and multiblock copolymers: Investigation of their drug encapsulation and release characteristics1, Journal of Controlled Release, vol.46, issue.3, pp.223-231, 1997. ,
DOI : 10.1016/S0168-3659(96)01597-0
Direct comparison of liposomal doxorubicin with or without polyethylene glycol coating in C-26 tumor-bearing mice: is surface coating with polyethylene glycol beneficial?, Clin Cancer Res, vol.5, issue.11, pp.3645-3652, 1999. ,
Polymer conjugates as anticancer nanomedicines, Nature Reviews Cancer, vol.54, issue.9, pp.688-701, 2006. ,
DOI : 10.1038/nrc1958
Effect of polyethylene glycol (PEG) chain organization on the physicochemical properties of poly(d, l-lactide) (PLA) based nanoparticles, European Journal of Pharmaceutics and Biopharmaceutics, vol.75, issue.2, pp.96-106, 2010. ,
DOI : 10.1016/j.ejpb.2010.03.002
Drug and gene targeting to the brain via blood???brain barrier receptor-mediated transport systems, International Congress Series, vol.1277, pp.49-62, 2005. ,
DOI : 10.1016/j.ics.2005.02.011
Brain targeting using novel lipid nanovectors, Journal of Controlled Release, vol.126, issue.1, pp.44-49, 2008. ,
DOI : 10.1016/j.jconrel.2007.11.001
URL : https://hal.archives-ouvertes.fr/inserm-00258097
Transferrin receptor on glioblastoma multiforme, J Neurosurg, vol.74, issue.2, p.313 ,
Targeting Anti???Transferrin Receptor Antibody (OX26) and OX26-Conjugated Liposomes to Brain Capillary Endothelial Cells Using In Situ Perfusion, Journal of Cerebral Blood Flow & Metabolism, vol.14, issue.11, pp.1193-1204, 2004. ,
DOI : 10.1097/01.WCB.0000135592.28823.47
Neurofilaments Bind Tubulin and Modulate Its Polymerization, Journal of Neuroscience, vol.29, issue.35, pp.11043-11054, 2009. ,
DOI : 10.1523/JNEUROSCI.1924-09.2009
A peptide corresponding to a neurofilament tubulinbinding site targets glioma cells and inhibits their proliferation ,
Introduction, Investigational New Drugs, vol.21, issue.2, pp.139-140, 2003. ,
DOI : 10.1163/9789004285620_002
The role of chemotherapy in the treatment of gliomas in adults, Cancer Treatment Reviews, vol.16, issue.3, pp.129-160, 1989. ,
DOI : 10.1016/0305-7372(89)90007-8
Ocular and Orbital Toxicity Following Intracarotid Injection of BCNU (Carmustine) and Cisplatinum for Malignant Gliomas, Ophthalmology, vol.92, issue.3, pp.402-406, 1985. ,
DOI : 10.1016/S0161-6420(85)34036-8
Ocular and Orbital Toxicity After Intracarotid Cisplatin Therapy, American Journal of Ophthalmology, vol.116, issue.4, pp.508-509, 1993. ,
DOI : 10.1016/S0002-9394(14)71417-5
Severe ocular and orbital toxicity after intracarotid etoposide phosphate and carboplatin therapy, American Journal of Ophthalmology, vol.127, issue.2, pp.230-233, 1999. ,
DOI : 10.1016/S0002-9394(98)00346-8
Ocular and Orbital Complications of Intraarterial Cisplatin A Case Report, Journal of Neuro-Ophthalmology, vol.17, issue.3, pp.195-198, 1997. ,
DOI : 10.1097/00041327-199709000-00010
Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer, Clin Oncol (R Coll Radiol), vol.13, issue.6, pp.438-440, 2001. ,
Intracarotid Delivery of Drugs, Anesthesiology, vol.109, issue.3, pp.543-564, 2008. ,
DOI : 10.1097/ALN.0b013e318182c81b
Evans blue distribution in the rate brain after intracarotid injection with the blood-brain barrier intact and open to osmosis, Sb Lek, vol.104, issue.3, pp.255-262, 2003. ,
High interstitial fluid pressure ??? an obstacle in cancer therapy, Nature Reviews Cancer, vol.74, issue.10, pp.806-813, 2004. ,
DOI : 10.1038/74725
Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization, Microvascular Research, vol.74, issue.2-3, pp.72-84, 2007. ,
DOI : 10.1016/j.mvr.2007.05.003
URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2100036
Ferrocene-mediated protoncoupled electron transfer in a series of ferrocifen-type breast-cancer drug candidates ,
and growth reduction of implanted glioma, FEBS Letters, vol.259, issue.5, pp.962-966, 2007. ,
DOI : 10.1016/j.febslet.2007.01.079
URL : https://hal.archives-ouvertes.fr/hal-00166409
Current and future strategies for the treatment of malignant brain tumors, Pharmacology & Therapeutics, vol.98, issue.1, pp.71-108, 2003. ,
DOI : 10.1016/S0163-7258(03)00014-7
The utility of Ki-67 and BrdU as proliferative markers of adult neurogenesis, Journal of Neuroscience Methods, vol.115, issue.1, pp.97-105, 2002. ,
DOI : 10.1016/S0165-0270(02)00007-9
Neuronal apoptosis studied by a sequential TUNEL technique: a method for tract-tracing, Brain Research Protocols, vol.4, issue.2, pp.140-146, 1999. ,
DOI : 10.1016/S1385-299X(99)00012-4
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma, New England Journal of Medicine, vol.352, issue.10, pp.987-996, 2005. ,
DOI : 10.1056/NEJMoa043330
Vo Phung Nguyen The Fifth Indochina Conference on Pharmaceutical Sciences, 2007. ,
Nguyen Hoang Anh The Fifth Indochina Conference on Pharmaceutical Sciences, 2007. ,
Synthesis and anti-HIV evaluation of hybrid-type prodrugs conjugating HIV integrase inhibitors with d4t by self-cleavable spacers containing an amino acid residue, Journal of Enzyme Inhibition and Medicinal Chemistry, vol.56, issue.4, pp.608-619, 2007. ,
DOI : 10.1021/jm00020a007
Hypolipidemic effect of extracts from Abelmoschus esculentus L. ? Malvaceae on tyloxapol -induced hyperlipidemia in mice ,
Dose effect activity of ferrocifen-loaded lipid nanocapsules on a 9L-glioma model, International Journal of Pharmaceutics, vol.379, issue.2, pp.317-323, 2009. ,
DOI : 10.1016/j.ijpharm.2009.05.031
URL : https://hal.archives-ouvertes.fr/hal-01230396
Lipid nanocapsules: A new platform for nanomedicine, International Journal of Pharmaceutics, vol.379, issue.2, pp.201-209, 2009. ,
DOI : 10.1016/j.ijpharm.2009.04.026
The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting, Nanomedicine, vol.5, issue.9, pp.1415-1433, 2010. ,
DOI : 10.2217/nnm.10.113
Administration-dependent efficacy of ferrociphenol lipid nanocapsules for the treatment of intracranial 9L rat gliosarcoma, International Journal of Pharmaceutics, vol.423, issue.1, 2011. ,
DOI : 10.1016/j.ijpharm.2011.04.037
Treatment of 9L gliosarcoma in rats by ferrociphenol loaded lipid nanocapsules based on passive targeting strategy through EPR effect. Submitted for publication in Pharmaceutical Research An active targeting strategy through ferrociphenol-loaded lipid nanocapsules for the treatment of 9L rat gliosarcoma ,
Ferrociphenol loaded lipid nanocapsules deliver by mesenchymal stem cells in brain tumor therapy, International Journal of Pharmaceutics ,